Article By:
Investing Whisperer
Sunday, December 22, 2019 5:36 PM EDT
Stereotaxis is a medical device company with flat to declining revenue…yet the stock has quadrupled in 2019. The stock has more to do with a competitive takeover at 60x sales than its own financials.